Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alberto Ruol

Showing results (31-40 of 57) with videos related to

Pageof 6
Sort By:
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|September 24, 2008
Zenker's diverticula: feasibility of a tailored approach based on diverticulum sizeChristian Rizzetto, Giovanni Zaninotto, Mario Costantini, et al.
Human Pathology|January 6, 2012
Human epithelial growth factor receptor 2 (HER2) status in primary and metastatic esophagogastric junction adenocarcinomasMatteo Fassan, Kathrin Ludwig, Marco Pizzi, et al.
Cancer Chemotherapy and Pharmacology|October 1, 2008
Multi-center phase II trial of chemo-radiotherapy with 5-fluorouracil, leucovorin and oxaliplatin in locally advanced esophageal cancerVanna Chiarion-Sileni, Roberto Innocente, Raffaele Cavina, et al.
Pharmacogenetics and Genomics|August 22, 2013
ERCC1 C8092A (rs3212986) polymorphism as a predictive marker in esophageal cancer patients treated with cisplatin/5-FU-based neoadjuvant therapyEnrica Rumiato, Francesco Cavallin, Elisa Boldrin, et al.
Annals of Surgery|December 19, 2008
Four hundred laparoscopic myotomies for esophageal achalasia: a single centre experienceGiovanni Zaninotto, Mario Costantini, Christian Rizzetto, et al.
Translational Research : the Journal of Laboratory and Clinical Medicine|January 17, 2016
A germline predictive signature of response to platinum chemotherapy in esophageal cancerEnrica Rumiato, Elisa Boldrin, Sandro Malacrida, et al.
Chirurgia Italiana|September 27, 2006
[Multimodal treatment in locally advanced esophageal cancer: a multicenter phase II study with neoadjuvant oxaliplatin, 5-fluorouracil, leucovorin and neoadjuvant radiotherapy: preliminary results]Matteo Cagol, Alberto Ruol, Vanna Chiarion Sileni, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|June 26, 2013
Complete clinical response after neoadjuvant chemoradiotherapy for squamous cell cancer of the thoracic oesophagus: is surgery always necessary?Carlo Castoro, Marco Scarpa, Matteo Cagol, et al.
Annals of Surgical Oncology|August 24, 2007
Effects of neoadjuvant therapy on perioperative morbidity in elderly patients undergoing esophagectomy for esophageal cancerAlberto Ruol, Giuseppe Portale, Carlo Castoro, et al.
International Journal of Cancer|May 4, 2006
Survivin in esophageal cancer: An accurate prognostic marker for squamous cell carcinoma but not adenocarcinomaAntonio Rosato, Michela Pivetta, Anna Parenti, et al.
Pageof 6

Showing results (31-40 of 57) with videos related to

Sort By:
Pageof 6
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|September 24, 2008
Zenker's diverticula: feasibility of a tailored approach based on diverticulum sizeChristian Rizzetto, Giovanni Zaninotto, Mario Costantini, et al.
Human Pathology|January 6, 2012
Human epithelial growth factor receptor 2 (HER2) status in primary and metastatic esophagogastric junction adenocarcinomasMatteo Fassan, Kathrin Ludwig, Marco Pizzi, et al.
Cancer Chemotherapy and Pharmacology|October 1, 2008
Multi-center phase II trial of chemo-radiotherapy with 5-fluorouracil, leucovorin and oxaliplatin in locally advanced esophageal cancerVanna Chiarion-Sileni, Roberto Innocente, Raffaele Cavina, et al.
Pharmacogenetics and Genomics|August 22, 2013
ERCC1 C8092A (rs3212986) polymorphism as a predictive marker in esophageal cancer patients treated with cisplatin/5-FU-based neoadjuvant therapyEnrica Rumiato, Francesco Cavallin, Elisa Boldrin, et al.
Annals of Surgery|December 19, 2008
Four hundred laparoscopic myotomies for esophageal achalasia: a single centre experienceGiovanni Zaninotto, Mario Costantini, Christian Rizzetto, et al.
Translational Research : the Journal of Laboratory and Clinical Medicine|January 17, 2016
A germline predictive signature of response to platinum chemotherapy in esophageal cancerEnrica Rumiato, Elisa Boldrin, Sandro Malacrida, et al.
Chirurgia Italiana|September 27, 2006
[Multimodal treatment in locally advanced esophageal cancer: a multicenter phase II study with neoadjuvant oxaliplatin, 5-fluorouracil, leucovorin and neoadjuvant radiotherapy: preliminary results]Matteo Cagol, Alberto Ruol, Vanna Chiarion Sileni, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|June 26, 2013
Complete clinical response after neoadjuvant chemoradiotherapy for squamous cell cancer of the thoracic oesophagus: is surgery always necessary?Carlo Castoro, Marco Scarpa, Matteo Cagol, et al.
Annals of Surgical Oncology|August 24, 2007
Effects of neoadjuvant therapy on perioperative morbidity in elderly patients undergoing esophagectomy for esophageal cancerAlberto Ruol, Giuseppe Portale, Carlo Castoro, et al.
International Journal of Cancer|May 4, 2006
Survivin in esophageal cancer: An accurate prognostic marker for squamous cell carcinoma but not adenocarcinomaAntonio Rosato, Michela Pivetta, Anna Parenti, et al.
Pageof 6